Echinacea purpurea for prevention of experimental rhinovirus colds.

Abstract

A randomized, double-blind, placebo-controlled clinical trial was conducted to evaluate the ability of Echinacea purpurea to prevent infection with rhinovirus type 39 (RV-39). Forty-eight previously healthy adults received echinacea or placebo, 2.5 mL 3 times per day, for 7 days before and 7 days after intranasal inoculation with RV-39. Symptoms were assessed to evaluate clinical illness. Viral culture and serologic studies were performed to evaluate the presence of rhinovirus infection. A total of 92% of echinacea recipients and 95% of placebo recipients were infected. Colds developed in 58% of echinacea recipients and 82% of placebo recipients (P=.114, by Fisher's exact test). Administration of echinacea before and after exposure to rhinovirus did not decrease the rate of infection; however, because of the small sample size, statistical hypothesis testing had relatively poor power to detect statistically significant differences in the frequency and severity of illness.

Statistics

0102030'04'05'06'07'08'09'10'11'12'13'14'15'16'17
Citations per Year

99 Citations

Semantic Scholar estimates that this publication has 99 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Sperber2004EchinaceaPF, title={Echinacea purpurea for prevention of experimental rhinovirus colds.}, author={Steven J Sperber and Leena P Shah and Richard D Gilbert and Thomas W Ritchey and Arnold S Monto}, journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America}, year={2004}, volume={38 10}, pages={1367-71} }